TAM-RADA16-I provided an environment for hADSCs to attach and proliferate, while RADA16-I attenuated the toxic effect of TAM on hADSCs but maintained the toxic effect on BC cells, a difference that may be due to the fact that MCF-7 cells have more estrogen receptors. The gene discussed is ESR1; the disease is breast cancer.